MARISSA J TADI
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner IRVINE, CA NPI 1245754258
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner CA ABBVIE INC. All categories
General Payments — all program years on this page
$2,713.09
- Category: General Payments
- Program years: PY2021–2024
- Record count: 136
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $207.10 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $207.10 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $66.26 | 3 |
| JAZZ PHARMACEUTICALS INC. | $41.85 | 2 |
| Janssen Scientific Affairs, LLC | $32.58 | 1 |
| Gilead Sciences, Inc. | $23.85 | 1 |
| GlaxoSmithKline, LLC. | $22.36 | 1 |
| BeiGene USA, Inc. | $20.20 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078844855 | Janssen Scientific Affairs, LLC | $32.58 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1108282354 | ABBVIE INC. | $19.24 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1108282356 | ABBVIE INC. | $29.65 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1108282358 | ABBVIE INC. | $17.37 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116556885 | GlaxoSmithKline, LLC. | $22.36 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1120860635 | BeiGene USA, Inc. | $20.20 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133656284 | Gilead Sciences, Inc. | $23.85 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151299462 | JAZZ PHARMACEUTICALS INC. | $25.84 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151299464 | JAZZ PHARMACEUTICALS INC. | $16.01 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.